GlaxoSmithKline PLC Director/PDMR Shareholding (1880L)
04 Septiembre 2019 - 3:33AM
UK Regulatory
TIDMGSK
RNS Number : 1880L
GlaxoSmithKline PLC
04 September 2019
GlaxoSmithKline plc (the 'Company')
Transaction notification
1. Details of PDMR/person closely associated with them
('PCA')
==== ===========================================================================================
a) Name Ms D Conrad
==== ======================================== =================================================
b) Position/status SVP, Human Resources
==== ======================================== =================================================
c) Initial notification/ Initial notification
amendment
==== ======================================== =================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ===========================================================================================
a) Name GlaxoSmithKline plc
==== ======================================== =================================================
b) LEI 5493000HZTVUYLO1D793
==== ======================================== =================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ===========================================================================================
a) Description of American Depositary Shares ('ADSs')
the financial ISIN: US37733W1053
instrument
==== ======================================== =================================================
b) Nature of the Purchase of ADSs jointly with Mr C J Conrad,
transaction a PCA.
==== ======================================== =================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ======================================== ===================== =======================
$41.75 1,800
===================== =======================
d) Aggregated information N/A (single transaction)
====
Aggregated volume
Price
========================================= =====================================================
e) Date of the transaction 2019-08-30
==== ======================================== =================================================
f) Place of the New York Stock Exchange (XNYS)
transaction
==== ======================================== =================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== =========================================================================================
a) Name Mr C J Conrad
==== ======================================== ===============================================
b) Position/status PCA of Ms D Conrad (SVP, Human Resources)
==== ======================================== ===============================================
c) Initial notification/ Initial notification
amendment
==== ======================================== ===============================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== =========================================================================================
a) Name GlaxoSmithKline plc
==== ======================================== ===============================================
b) LEI 5493000HZTVUYLO1D793
==== ======================================== ===============================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== =========================================================================================
a) Description of American Depositary Shares ('ADSs')
the financial ISIN: US37733W1053
instrument
==== ======================================== ===============================================
b) Nature of the Purchase of ADSs jointly with Ms D Conrad,
transaction a PDMR.
==== ======================================== ===============================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ======================================== ==================== ======================
$41.75 1,800
==================== ======================
d) Aggregated information N/A (single transaction)
====
Aggregated volume
Price
========================================= ===================================================
e) Date of the transaction 2019-08-30
==== ======================================== ===============================================
f) Place of the New York Stock Exchange (XNYS)
transaction
==== ======================================== ===============================================
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
DSHVZLBBKKFXBBB
(END) Dow Jones Newswires
September 04, 2019 04:33 ET (08:33 GMT)
Gsk (LSE:GSK)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Gsk (LSE:GSK)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024